Home LiteratureArticle Details
PMID: 17621267 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.

Oncogene ·Vol. 27 ·No. 3 ·2008-01-10 ·Pages 378-86

Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T

Abstract

Interleukin-6 (IL-6) is overexpressed and contributes to tumor cell growth in cholangiocarcinoma. Enforced IL-6 production can alter the expression of specific microRNAs (miRNAs) involved in tumor growth, and moreover can modulate expression of methylation-dependent genes. Thus, we assessed the methylation-dependent regulation of miRNA expression in human malignant cholangiocytes stably transfected to overexpress IL-6. The expression of the methyltransferases DNA methyltransferase enzyme-1 and HASJ4442 was increased by IL-6 overexpression, but was decreased by the methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-CdR). Expression profiling identified seven miRNAs that were significantly downregulated by IL-6 overexpression (<0.4-fold) and upregulated (>2-fold) by 5-aza-CdR. One of these, miR-370, is embedded in a CpG island. Although 5-aza-CdR increased miR-370 expression by 2.1-fold in malignant cells, the expression in nonmalignant cells was unchanged. The oncogene mitogen-activated protein kinase kinase kinase 8 (MAP3K8) was identified as a target of miR-370, and its expression was decreased by 5-aza-CdR in cholangiocarcinoma cells. Overexpression of IL-6 reduced miR-370 expression and reinstated MAP3K8 expression in vitro as well as in tumor cell xenografts in vivo. Thus, IL-6 may contribute to tumor growth by modulation of expression of selected miRNAs, such as miR-370. These studies define a mechanism by which inflammation-associated cytokines can epigenetically modulate gene expression and directly contribute to tumor biology.

MeSH Terms
Azacitidine/analogs & derivatives,pharmacology Bile Duct Neoplasms/genetics Bile Ducts, Intrahepatic/metabolism Cell Line, Tumor Cell Proliferation Cholangiocarcinoma/genetics DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases/antagonists & inhibitors,metabolism DNA Methylation/drug effects Decitabine Epigenesis, Genetic Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Interleukin-6/genetics,metabolism MAP Kinase Kinase Kinases/genetics,metabolism MicroRNAs/genetics Proto-Oncogene Proteins/genetics,metabolism
Chemicals
Interleukin-6 MIRN370 microRNA, human MicroRNAs Proto-Oncogene Proteins Decitabine DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases MAP Kinase Kinase Kinases MAP3K8 protein, human Azacitidine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Meng F
Department of Internal Medicine, Scott and White Clinic, Texas A&M University System Health Science Center College of Medicine, Temple, TX, USA.
Wehbe-Janek H
Henson R
Smith H
Patel T
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2008-01-10
Epub
2007-00-09
Pages
378-86
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NIDDK NIH HHS · R01 DK069370 · United States
NIDDK NIH HHS · R01 DK069370-02 · United States
NIDDK NIH HHS · DK069370 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com